Status:
RECRUITING
SafeTy and Outcome of contemPorary Treatment Strategies for Cardiogenic SHOCK
Lead Sponsor:
Universitätsklinikum Hamburg-Eppendorf
Conditions:
Cardiogenic Shock
Eligibility:
All Genders
18+ years
Brief Summary
International, observational registry to investigate the outcome in patients with cardiogenic shock. The primary aim of this study is to investigate the clinical outcome of patients in cardiogenic sho...
Detailed Description
There is a focus on interventional therapies, mechanical circulatory support and new cardiovascular therapeutics in patients with cardiogenic shock (CS). The investigators will describe current practi...
Eligibility Criteria
Inclusion
- Patients with cardiogenic shock treated at a tertiary care hospital.
Exclusion
- Age ≤17 years.
Key Trial Info
Start Date :
September 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2031
Estimated Enrollment :
2500 Patients enrolled
Trial Details
Trial ID
NCT03313687
Start Date
September 1 2017
End Date
December 31 2031
Last Update
October 7 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Heart Center
Hamburg, Germany